title: Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.
abstract: In conclusion, it was the differential responses of slow and rapid acetylators to procainamide therapy that gave the initial clues that acetylprocainamide might be a safer drug than procainamide. So far, the experience with acetylprocainamide has been encouraging.
mesh_terms: D000120:Acecainide / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D000107:Acetylation; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D007536:Isomerism; D007700:Kinetics; D011342:Procainamide / Q000031:analogs & derivatives* / Q000378:metabolism
chemical_list: D000120:Acecainide; D011342:Procainamide